Dec 6, 2024 · Among these diseases, monoclonal gammopathy of neurological significance (MGNS) constitutes a real challenge, both diagnostically and therapeutically. Diagnosis is particularly difficult …

Dec 16, 2024 · In patients with MGUS and coexistent PN, it is essential to understand the etiology of the neuropathy and establish whether there is a connection between the peripheral neuropathy and the …

Dec 9, 2025 · Understand the complex link between Monoclonal Gammopathy (MGUS) and peripheral neuropathy, including causal mechanisms and treatment options.

In patients with MGUS and coexistent PN, it is essential to understand the etiology of the neuropathy and establish whether there is a connection between the peripheral neu-ropathy and the monoclonal …

This article discusses how to approach patients with monoclonal gammopathy and peripheral neuropathy, highlighting clinical and laboratory clues that may aid in establishing a diagnosis in a …

Studies addressing the optimal approach to diagnosis and management of this entity are limited. In addition to a review of the literature, we present a diagnostic approach to patients with monoclonal …

In addition to a review of the literature, we present a diagnostic approach to patients with monoclonal gammopathy–associated peripheral neuropathy and discuss available data and options for treatment.

Nov 1, 2021 · Monoclonal gammopathy of undetermined significance (MGUS) and peripheral neuropathy often occur together, with nerve damage causing symptoms like weakness, numbness, …

Monoclonal gammopathy of undetermined significance (MGUS) is a plasma cell dyscrasia in which plasma cells or other types of antibody-producing cells secrete a myeloma protein, i.e. an abnormal …

Dec 18, 2000 · A rational approach to the investigation of patients with polyneuropathy and monoclonal gammopathy is presented based on the clinical and electrophysiological features, as well as the …